Search research articles
Contact Us
Filters
Showing results (111-120 of 131) with videos related to
Page
of 14
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 13, 1999
Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy
F S Nielsen, H P Hansen, P Jacobsen, et al.
Kidney International
|
March 14, 2008
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes
F Persson, P Rossing, K J Schjoedt, et al.
American Journal of Hypertension
|
May 1, 1992
Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension
M A Gall, P Rossing, P Skøtt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 1, 1997
Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathy
F S Nielsen, S Ali, P Rossing, et al.
Immunobiology
|
May 9, 2020
Association between severe diabetic retinopathy and lectin pathway proteins - an 18-year follow-up study with newly diagnosed type 1 diabetes patients
C B Holt, I T Hoffmann-Petersen, T K Hansen, et al.
Diabetologia
|
July 4, 2012
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study
J W M Nin, I Ferreira, C G Schalkwijk, et al.
Ugeskrift for Laeger
|
March 1, 1993
[The effect of captopril, metoprolol and hydrochlorothiazide therapy in patients with non-insulin-dependent diabetes (NIDDM) and primary hypertension. A double-blind, randomized cross-over study]
M A Gall, P Rossing, P Skøtt, et al.
Diabetologia
|
May 19, 2010
Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial
F Persson, P Rossing, H Reinhard, et al.
Journal of Human Hypertension
|
March 27, 2015
Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia--the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)
S Theilade, B Claggett, T W Hansen, et al.
Journal of Diabetes and Its Complications
|
July 30, 2016
High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes
Emilie H Zobel, Bernt J von Scholten, Maria Lajer, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 131) with videos related to
Sort By:
Page
of 14
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 13, 1999
Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy
F S Nielsen, H P Hansen, P Jacobsen, et al.
Kidney International
|
March 14, 2008
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes
F Persson, P Rossing, K J Schjoedt, et al.
American Journal of Hypertension
|
May 1, 1992
Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension
M A Gall, P Rossing, P Skøtt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 1, 1997
Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathy
F S Nielsen, S Ali, P Rossing, et al.
Immunobiology
|
May 9, 2020
Association between severe diabetic retinopathy and lectin pathway proteins - an 18-year follow-up study with newly diagnosed type 1 diabetes patients
C B Holt, I T Hoffmann-Petersen, T K Hansen, et al.
Diabetologia
|
July 4, 2012
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study
J W M Nin, I Ferreira, C G Schalkwijk, et al.
Ugeskrift for Laeger
|
March 1, 1993
[The effect of captopril, metoprolol and hydrochlorothiazide therapy in patients with non-insulin-dependent diabetes (NIDDM) and primary hypertension. A double-blind, randomized cross-over study]
M A Gall, P Rossing, P Skøtt, et al.
Diabetologia
|
May 19, 2010
Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial
F Persson, P Rossing, H Reinhard, et al.
Journal of Human Hypertension
|
March 27, 2015
Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia--the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)
S Theilade, B Claggett, T W Hansen, et al.
Journal of Diabetes and Its Complications
|
July 30, 2016
High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes
Emilie H Zobel, Bernt J von Scholten, Maria Lajer, et al.
Page
of 14